Virginia Retirement Systems Et Al Myriad Genetics Inc Transaction History

Virginia Retirement Systems Et Al

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	BUY	$18.21 - $27.88 $207,594 - $317,832	11,400 New	11,400 $218 Million
Q3 2020 Nov 12, 2020	SELL	$11.25 - $14.75 $408,375 - $535,425	-36,300 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$10.69 - $16.49 $87,658 - $135,218	-8,200 Reduced 18.43%	36,300 $412,000
Q1 2020 May 12, 2020	SELL	$9.78 - $29.53 $18,582 - $56,107	-1,900 Reduced 4.09%	44,500 $637,000
Q4 2019 Jan 27, 2020	SELL	$20.93 - $35.1 $29,302 - $49,140	-1,400 Reduced 2.93%	46,400 $1.26 Million
Q3 2019 Oct 22, 2019	BUY	$22.08 - $47.08 $108,191 - $230,692	4,900 Added 11.42%	47,800 $1.37 Million
Q2 2019 Jul 26, 2019	BUY	$22.67 - $35.0 $47,607 - $73,500	2,100 Added 5.15%	42,900 $1.19 Million
Q1 2019 Apr 25, 2019	BUY	$26.93 - $34.7 $29,623 - $38,170	1,100 Added 2.77%	40,800 $1.36 Million
Q4 2018 Feb 07, 2019	BUY	$27.23 - $45.56 $364,882 - $610,504	13,400 Added 50.95%	39,700 $1.15 Million
Q3 2018 Nov 02, 2018	SELL	$37.57 - $50.34 $86,411 - $115,782	-2,300 Reduced 8.04%	26,300 $1.21 Million
Q2 2018 Aug 03, 2018	BUY	$27.75 - $40.17 $793,650 - $1.15 Million	28,600 New	28,600 $1.07 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.